Penumbra (PEN) Stock Forecast, Price Target & Predictions
PEN Stock Forecast
Penumbra stock forecast is as follows: an average price target of $224.85 (represents a -2.03% downside from PEN’s last price of $229.51) and a rating consensus of 'Buy', based on 14 wall street analysts offering a 1-year stock forecast.
PEN Price Target
The average price target for Penumbra (PEN) is $224.85 based on 1-year price targets from 14 Wall Street analysts in the past 3 months, with a price target range of $285.00 to $150.00. This represents a potential -2.03% downside from PEN's last price of $229.51.
PEN Analyst Ratings
According to 14 Wall Street analysts, Penumbra's rating consensus is 'Buy'. The analyst rating breakdown for PEN stock is 0 'Strong Buy' (0.00%), 7 'Buy' (50.00%), 7 'Hold' (50.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Penumbra Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Oct 31, 2024 | Matt O'Brien | Piper Sandler | $235.00 | $211.29 | 11.22% | 2.39% |
| Oct 31, 2024 | Pito Chickering | Deutsche Bank | $241.00 | $211.29 | 14.06% | 5.01% |
| Oct 18, 2024 | Matt O'Brien | Piper Sandler | $225.00 | $202.26 | 11.24% | -1.97% |
| Oct 16, 2024 | Jason Mills | Canaccord Genuity | $235.00 | $206.62 | 13.74% | 2.39% |
| Oct 15, 2024 | David Rescott | Robert W. Baird | $244.00 | $211.36 | 15.44% | 6.31% |
| Oct 14, 2024 | Richard Newitter | Truist Financial | $235.00 | $214.92 | 9.34% | 2.39% |
| Oct 08, 2024 | Shagun Singh | RBC Capital | $222.00 | $190.81 | 16.35% | -3.27% |
| Sep 17, 2024 | Matthew Blackman | Stifel Nicolaus | $238.00 | $187.06 | 27.23% | 3.70% |
| Sep 03, 2024 | Mike Kratky | Leerink Partners | $263.00 | $202.32 | 29.99% | 14.59% |
| Jul 31, 2024 | Richard Newitter | Truist Financial | $200.00 | $173.09 | 15.55% | -12.86% |
The latest Penumbra stock forecast, released on Oct 31, 2024 by Matt O'Brien from Piper Sandler, set a price target of $235.00, which represents a 11.22% increase from the stock price at the time of the forecast ($211.29), and a 2.39% increase from PEN last price ($229.51).
Penumbra Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | 7 | 9 | 16 |
| Avg Price Target | $233.86 | $237.56 | $218.44 |
| Last Closing Price | $229.51 | $229.51 | $229.51 |
| Upside/Downside | 1.90% | 3.51% | -4.82% |
In the current month, the average price target of Penumbra stock is $233.86, according to 7 Wall Street analysts offering twelve months forecast. The average price target represents a 1.90% increase as opposed to Penumbra's last price of $229.51. This month's average price target is down -1.56% compared to last quarter, and up 7.06% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Oct 31, 2024 | RBC Capital | Outperform | Outperform | Hold |
| Oct 31, 2024 | Deutsche Bank | Buy | Buy | Hold |
| Oct 18, 2024 | Piper Sandler | Overweight | Overweight | Hold |
| Oct 16, 2024 | Canaccord Genuity | Buy | Buy | Hold |
| Oct 15, 2024 | Wells Fargo | Equal-Weight | Equal-Weight | Hold |
| Oct 14, 2024 | BTIG | Buy | Buy | Hold |
| Oct 08, 2024 | RBC Capital | Outperform | Outperform | Hold |
| Aug 28, 2024 | BTIG | Buy | Buy | Hold |
| Aug 22, 2024 | Citigroup | Neutral | Neutral | Hold |
| Jul 31, 2024 | Wells Fargo | - | Equal-Weight | Downgrade |
Penumbra's last stock rating was published by RBC Capital on Oct 31, 2024. The company gave PEN a "Outperform" rating, the same as its previous rate.
Penumbra Financial Forecast
Penumbra Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | $270.95M | $261.50M | $241.40M | $221.22M | $213.68M | $208.34M | $203.90M | $204.01M | $190.12M | $184.26M | $169.20M | $166.90M | $151.08M | $105.11M | $137.33M | $145.26M | $139.50M |
| Avg Forecast | $406.29M | $389.31M | $387.39M | $361.01M | $360.34M | $345.21M | $338.12M | $316.36M | $311.38M | $297.36M | $298.24M | $275.20M | $286.62M | $265.38M | $253.59M | $229.68M | $217.33M | $212.49M | $206.24M | $195.39M | $194.29M | $181.06M | $170.77M | $152.64M | $155.40M | $124.95M | $100.74M | $136.28M | $141.40M | $133.98M |
| High Forecast | $425.36M | $407.59M | $405.58M | $377.96M | $377.26M | $361.42M | $354.00M | $321.04M | $315.97M | $298.19M | $298.24M | $275.40M | $289.63M | $267.32M | $265.50M | $240.47M | $227.53M | $212.49M | $206.24M | $195.39M | $194.29M | $181.06M | $170.77M | $152.64M | $155.40M | $124.95M | $100.74M | $136.28M | $141.40M | $133.98M |
| Low Forecast | $398.00M | $381.37M | $379.49M | $353.64M | $352.99M | $338.17M | $331.23M | $311.55M | $306.18M | $296.53M | $298.24M | $275.01M | $283.25M | $264.12M | $248.42M | $225.00M | $212.90M | $212.49M | $206.24M | $195.39M | $194.29M | $181.06M | $170.77M | $152.64M | $155.40M | $124.95M | $100.74M | $136.28M | $141.40M | $133.98M |
| # Analysts | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 8 | 13 | 7 | 3 | 4 | 7 | 12 | 9 | 9 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 9 | 15 | 9 | 9 | 8 | 8 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.02% | 1.03% | 1.05% | 1.02% | 1.01% | 1.01% | 1.04% | 1.05% | 1.05% | 1.08% | 1.11% | 1.07% | 1.21% | 1.04% | 1.01% | 1.03% | 1.04% |
Penumbra's average Quarter revenue forecast for Dec 23 based on 7 analysts is $286.62M, with a low forecast of $283.25M, and a high forecast of $289.63M. PEN's average Quarter revenue forecast represents a 5.79% increase compared to the company's last Quarter revenue of $270.95M (Sep 23).
Penumbra EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 8 | 13 | 7 | 3 | 4 | 7 | 12 | 9 | 9 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 9 | 15 | 9 | 9 | 8 | 8 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | $12.63M | $17.89M | $8.01M | $4.83M | $11.66M | $5.79M | $1.68M | $-35.20M | $12.23M | $14.69M | $16.85M | $3.96M | $-15.33M | $-12.96M | $2.75M | $14.45M | $15.50M |
| Avg Forecast | $10.91M | $10.46M | $10.40M | $9.70M | $9.68M | $9.27M | $9.08M | $8.50M | $8.36M | $7.99M | $8.01M | $980.22K | $7.70M | $7.13M | $6.81M | $1.05M | $-53.86M | $5.71M | $5.54M | $1.12M | $5.22M | $4.86M | $4.59M | $16.85M | $4.17M | $3.36M | $2.71M | $4.18M | $3.80M | $3.60M |
| High Forecast | $11.42M | $10.95M | $10.89M | $10.15M | $10.13M | $9.71M | $9.51M | $8.62M | $8.49M | $8.01M | $8.01M | $1.18M | $7.78M | $7.18M | $7.13M | $1.26M | $-43.09M | $5.71M | $5.54M | $1.35M | $5.22M | $4.86M | $4.59M | $20.22M | $4.17M | $3.36M | $2.71M | $5.01M | $3.80M | $3.60M |
| Low Forecast | $10.69M | $10.24M | $10.19M | $9.50M | $9.48M | $9.08M | $8.90M | $8.37M | $8.22M | $7.96M | $8.01M | $784.18K | $7.61M | $7.09M | $6.67M | $838.70K | $-64.63M | $5.71M | $5.54M | $897.00K | $5.22M | $4.86M | $4.59M | $13.48M | $4.17M | $3.36M | $2.71M | $3.34M | $3.80M | $3.60M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.77% | 2.63% | 7.64% | -0.09% | 2.04% | 1.05% | 1.50% | -6.75% | 2.52% | 3.20% | 1.00% | 0.95% | -4.57% | -4.79% | 0.66% | 3.81% | 4.31% |
7 analysts predict PEN's average Quarter EBITDA for Dec 23 to be $7.70M, with a high of $7.78M and a low of $7.61M. This is -39.02% lower than Penumbra's previous annual EBITDA (Sep 23) of $12.63M.
Penumbra Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 8 | 13 | 7 | 3 | 4 | 7 | 12 | 9 | 9 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 9 | 15 | 9 | 9 | 8 | 8 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | $9.21M | $18.96M | $8.56M | $3.88M | $-2.27M | $-3.69M | $79.00K | $-24.63M | $8.85M | $9.23M | $11.84M | $3.65M | $-8.81M | $-11.96M | $1.43M | $9.69M | $11.48M |
| Avg Forecast | $57.29M | $47.73M | $41.81M | $34.73M | $45.34M | $40.61M | $35.88M | $27.88M | $34.64M | $26.92M | $21.77M | $134.67K | $27.38M | $17.80M | $10.96M | $144.04K | $-37.69M | $-149.16K | $-1.21M | $154.05K | $6.85M | $6.28M | $6.38M | $11.84M | $3.36M | $-3.77M | $-16.80M | $2.16M | $7.45M | $6.55M |
| High Forecast | $60.78M | $50.65M | $44.36M | $36.85M | $48.10M | $43.09M | $38.07M | $33.31M | $43.51M | $27.52M | $21.78M | $161.61K | $33.55M | $20.96M | $11.62M | $172.84K | $-30.15M | $-149.16K | $-1.21M | $184.86K | $6.85M | $6.28M | $6.38M | $14.20M | $3.36M | $-3.77M | $-16.80M | $2.60M | $7.45M | $6.55M |
| Low Forecast | $55.77M | $46.47M | $40.70M | $33.81M | $44.13M | $39.54M | $34.93M | $21.36M | $29.41M | $26.31M | $21.76M | $107.74K | $22.36M | $15.82M | $10.67M | $115.23K | $-45.23M | $-149.16K | $-1.21M | $123.24K | $6.85M | $6.28M | $6.38M | $9.47M | $3.36M | $-3.77M | $-16.80M | $1.73M | $7.45M | $6.55M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.52% | 1.73% | 59.44% | -0.10% | 15.23% | 3.04% | 0.51% | -3.60% | 1.41% | 1.45% | 1.00% | 1.09% | 2.34% | 0.71% | 0.66% | 1.30% | 1.75% |
Penumbra's average Quarter net income forecast for Dec 23 is $27.38M, with a range of $22.36M to $33.55M. PEN's average Quarter net income forecast represents a 197.13% increase compared to the company's last Quarter net income of $9.21M (Sep 23).
Penumbra SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 8 | 13 | 7 | 3 | 4 | 7 | 12 | 9 | 9 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 9 | 15 | 9 | 9 | 8 | 8 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | $125.92M | $127.44M | $123.08M | $115.63M | $108.57M | $114.61M | $110.90M | $113.50M | $94.40M | $90.64M | $79.80M | $76.60M | $76.16M | $59.85M | $74.45M | $74.69M | $69.29M |
| Avg Forecast | $205.24M | $196.67M | $195.70M | $182.37M | $182.03M | $174.39M | $170.81M | $159.82M | $157.30M | $150.22M | $150.66M | $189.06M | $144.79M | $134.06M | $128.11M | $202.20M | $173.65M | $107.34M | $104.19M | $98.71M | $98.15M | $91.46M | $86.27M | $79.80M | $78.51M | $63.12M | $50.89M | $113.06M | $71.43M | $67.68M |
| High Forecast | $214.88M | $205.90M | $204.89M | $190.93M | $190.58M | $182.58M | $178.83M | $162.18M | $159.62M | $150.64M | $150.66M | $226.87M | $146.31M | $135.04M | $134.12M | $242.64M | $208.39M | $107.34M | $104.19M | $98.71M | $98.15M | $91.46M | $86.27M | $95.76M | $78.51M | $63.12M | $50.89M | $135.67M | $71.43M | $67.68M |
| Low Forecast | $201.06M | $192.66M | $191.71M | $178.65M | $178.32M | $170.83M | $167.33M | $157.38M | $154.67M | $149.80M | $150.66M | $151.24M | $143.09M | $133.42M | $125.49M | $161.76M | $138.92M | $107.34M | $104.19M | $98.71M | $98.15M | $91.46M | $86.27M | $63.84M | $78.51M | $63.12M | $50.89M | $90.44M | $71.43M | $67.68M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.94% | 0.99% | 0.61% | 0.67% | 1.01% | 1.10% | 1.12% | 1.16% | 1.03% | 1.05% | 1.00% | 0.98% | 1.21% | 1.18% | 0.66% | 1.05% | 1.02% |
Penumbra's average Quarter SG&A projection for Dec 23 is $144.79M, based on 7 Wall Street analysts, with a range of $143.09M to $146.31M. The forecast indicates a 14.99% rise compared to PEN last annual SG&A of $125.92M (Sep 23).
Penumbra EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 8 | 13 | 7 | 3 | 4 | 7 | 12 | 9 | 9 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 9 | 15 | 9 | 9 | 8 | 8 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | $0.24 | $0.49 | $0.22 | $0.10 | $-0.06 | $-0.10 | - | $-0.66 | $0.24 | $0.25 | $0.32 | $0.10 | $-0.24 | $-0.34 | $0.04 | $0.28 | $0.33 |
| Avg Forecast | $1.46 | $1.22 | $1.07 | $0.89 | $1.16 | $1.04 | $0.92 | $0.71 | $0.88 | $0.69 | $0.56 | $0.39 | $0.70 | $0.45 | $0.28 | $0.11 | $0.15 | $-0.00 | $-0.03 | $0.04 | $0.18 | $0.16 | $0.16 | $0.09 | $0.09 | $-0.10 | $-0.43 | $0.13 | $0.19 | $0.17 |
| High Forecast | $1.55 | $1.29 | $1.13 | $0.94 | $1.23 | $1.10 | $0.97 | $0.85 | $1.11 | $0.70 | $0.56 | $0.39 | $0.86 | $0.54 | $0.30 | $0.12 | $0.16 | $-0.00 | $-0.03 | $0.04 | $0.18 | $0.16 | $0.16 | $0.09 | $0.09 | $-0.10 | $-0.43 | $0.13 | $0.19 | $0.17 |
| Low Forecast | $1.42 | $1.19 | $1.04 | $0.86 | $1.13 | $1.01 | $0.89 | $0.55 | $0.75 | $0.67 | $0.56 | $0.38 | $0.57 | $0.40 | $0.27 | $0.11 | $0.14 | $-0.00 | $-0.03 | $0.04 | $0.18 | $0.16 | $0.16 | $0.09 | $0.09 | $-0.10 | $-0.43 | $0.13 | $0.19 | $0.17 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.53% | 1.75% | 2.02% | 0.68% | 15.58% | 3.12% | 0.05% | -3.74% | 1.48% | 1.52% | 3.56% | 1.16% | 2.47% | 0.79% | 0.30% | 1.46% | 1.95% |
According to 7 Wall Street analysts, Penumbra's projected average Quarter EPS for Dec 23 is $0.70, with a low estimate of $0.57 and a high estimate of $0.86. This represents a 191.17% increase compared to PEN previous annual EPS of $0.24 (Sep 23).
Penumbra Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| TNDM | Tandem Diabetes Care | $32.85 | $81.22 | 147.25% | Buy |
| INMD | InMode | $17.38 | $27.50 | 58.23% | Hold |
| TMDX | TransMedics Group | $84.97 | $126.75 | 49.17% | Buy |
| IRTC | iRhythm | $81.44 | $121.17 | 48.78% | Buy |
| LIVN | LivaNova | $49.01 | $70.50 | 43.85% | Buy |
| CNMD | CONMED | $70.47 | $96.00 | 36.23% | Buy |
| NARI | Inari Medical | $48.93 | $66.11 | 35.11% | Buy |
| INSP | Inspire Medical Systems | $192.71 | $238.00 | 23.50% | Buy |
| DXCM | DexCom | $69.70 | $81.36 | 16.73% | Buy |
| PODD | Insulet | $237.44 | $270.93 | 14.10% | Buy |
| ITGR | Integer | $126.53 | $138.00 | 9.07% | Buy |
| MASI | Masimo | $147.39 | $160.20 | 8.69% | Buy |
| PEN | Penumbra | $229.51 | $224.85 | -2.03% | Buy |
| SWAV | ShockWave Medical | $334.75 | $258.17 | -22.88% | Hold |
PEN Forecast FAQ
Is Penumbra a good buy?
Yes, according to 14 Wall Street analysts, Penumbra (PEN) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 7 'Buy' recommendations, accounting for 50.00% of PEN's total ratings.
What is PEN's price target?
Penumbra (PEN) average price target is $224.85 with a range of $150 to $285, implying a -2.03% from its last price of $229.51. The data is based on 14 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Penumbra stock go up soon?
According to Wall Street analysts' prediction for PEN stock, the company can go down by -2.03% (from the last price of $229.51 to the average price target of $224.85), up by 24.18% based on the highest stock price target, and down by -34.64% based on the lowest stock price target.
Can Penumbra stock reach $300?
PEN's average twelve months analyst stock price target of $224.85 does not support the claim that Penumbra can reach $300 in the near future.
What is Penumbra's current price target trend?
7 Wall Street analysts forecast a $233.86 price target for Penumbra (PEN) this month, up 1.90% from its last price of $229.51. Compared to the last 3 and 12 months, the average price target increased by 3.51% and decreased by -4.82%, respectively.
What are Penumbra's analysts' financial forecasts?
Penumbra's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $1.36B (high $1.41B, low $1.33B), average EBITDA is $36.53M (high $37.97M, low $35.83M), average net income is $149.71M (high $162.58M, low $139.96M), average SG&A $687.05M (high $714.17M, low $673.87M), and average EPS is $3.82 (high $4.15, low $3.57). PEN's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $1.54B (high $1.62B, low $1.51B), average EBITDA is $41.47M (high $43.42M, low $40.62M), average net income is $181.55M (high $192.63M, low $176.74M), average SG&A $779.98M (high $816.6M, low $764.07M), and average EPS is $4.63 (high $4.92, low $4.51).
Did the PEN's actual financial results beat the analysts' financial forecasts?
Based on Penumbra's last annual report (Dec 2022), the company's revenue was $847.13M, beating the average analysts forecast of $831.45M by 1.89%. Apple's EBITDA was $6.08M, missing the average prediction of $-41.49M by -114.66%. The company's net income was $-2.002M, missing the average estimation of $-38.896M by -94.85%. Apple's SG&A was $449.72M, missing the average forecast of $483.89M by -7.06%. Lastly, the company's EPS was $-0.0529, missing the average prediction of $0.151 by -134.94%. In terms of the last quarterly report (Sep 2023), Penumbra's revenue was $270.95M, beating the average analysts' forecast of $265.38M by 2.10%. The company's EBITDA was $12.62M, beating the average prediction of $7.13M by 77.13%. Penumbra's net income was $9.21M, missing the average estimation of $17.8M by -48.24%. The company's SG&A was $125.92M, missing the average forecast of $134.06M by -6.07%. Lastly, the company's EPS was $0.24, missing the average prediction of $0.454 by -47.18%